GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension-Reference-Cited by-同舟云学术

GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension

Published:2020-11 Issue:5 Volume:33 Page:108271
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Sterling Jacob K.^ORCID,Adetunji Modupe O.^ORCID,Guttha Samyuktha,Bargoud Albert R.,Uyhazi Katherine E.^ORCID,Ross Ahmara G.^ORCID,Dunaief Joshua L.,Cui Qi N.^ORCID

Funder

NIH

Research to Prevent Blindness

F.M. Kirby Foundation

Paul and Evanina Bell Mackall Foundation Trust

American Glaucoma Society

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference47 articles.

1. A review of GLP-1 receptor agonists: evolution and advancement, through the lens of randomized controlled trials;Aroda;Diabetes Obes. Metab.,2018

2. The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson’s disease: mechanisms of action;Athauda;Drug Discov. Today,2016

3. New tools for studying microglia in the mouse and human CNS;Bennett;Proc. Natl. Acad. Sci. USA,2016

4. Complement C3-targeted gene therapy restricts onset and progression of neurodegeneration in chronic mouse glaucoma;Bosco;Mol. Ther.,2018

5. Association of tumour necrosis factor-alpha -308 G/A polymorphism with primary open-angle glaucoma;Bozkurt;Clin. Exp. Ophthalmol.,2012

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists Exposure and Intraocular Pressure Change;American Journal of Ophthalmology;2024-09

2. Complement anaphylatoxins: Potential therapeutic target for diabetic kidney disease;Diabetic Medicine;2024-08-27

3. Increased Pan-Type, A1-Type, and A2-Type Astrocyte Activation and Upstream Inflammatory Markers Are Induced by the P2X7 Receptor;International Journal of Molecular Sciences;2024-08-13

4. Microglia target synaptic sites early during excitatory circuit disassembly in neurodegeneration;2024-06-14

5. Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling;Acta Pharmaceutica Sinica B;2024-06